Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just looked at the online kanabo shop and they are selling their vape pod cartridges buy one get one free as they are approaching their use buy date. Maybe not selling as many as they thought they would.
@Bravosix
100% agree, positioning ready pre-placement. Two previous were a penny down on each other, so expecting similar, so maybe 3p placing or 2.5p placing depending on what support they can secure via the brokers. Does make perfect sense. Much slower burn to change UK habits than how HELD are positioning. We still need full visibility of financials though.
I do actually like the direction of the business plan here, i prefer it to HELDs business model despite HELD having buckets of cash. I think once this one has the financial stability and cash behind it KNB could prove to be the stronger play maybe?. Long way off just yet but could well get sexy in 2024 if they can get a) product validation which is key b) nationwide supply and distribution right and c) GP Network to be fully integrated with the medical product.
Two other thoughts:-
Can they incentivise UK GPs to prescribe their product? Is that unethical? and on prescribing it the supply to the local chemist needs to be in place. So I'm wondering how much stock they would need in production for UK Coverage? and they need the cash to fund that.
Having actually used the GP service its £40 to use the service plus the private prescription cost. Personally I would pay it but a lot wont but its still an additional reach to just the normal free doctors service.
If they have built up a 40,000 patient network so far that will include people that have used the service from anything from a Verruca on their big toe to contraception to flu and virus support to more serious issues - i wonder what percentage of that would need an inhaler for pain management?
Bottom line for me: If they can get enough cash behind them at the next placing it feels like that could be a good entry point providing its enough cash to do all of the above. I'm trying to avoid penny shares stuck in the middle of the raise spend cycle due to the continual dilution we face.
Looks like Elon Musk is allowing Cannabis advertising on twitter
https://www.firstpost.com/world/twitter-becomes-the-first-social-media-company-in-the-us-to-allow-cannabis-ads-12165872.html
https://mobile.twitter.com/ZaksTradersCafe/status/1625829651988856832?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet
Time to take off and I agree with Zak. Over 6p incoming.
Stay positive
Inevitably there will be sales and profit taking…. Nothing has changed …an SP will often dip and then take off again….
In the October investor presentation they talk about moving production to the UK in the first half of 2023.By doing so they expect to reduce production costs by 40%. That`s the vape carts not growing the product. So they will need to set up a small production facility if they are going to make good on that objective. That will need to be a sterile environment if its to produce medical grade products. No mention of it this time round but I was thinking this could be a significant cost, would they need to raise funds. not saying its a bad thing just wondering whether any progress has been made in this regard.
I don’t think it was waffle at all. It was a factual update on the foundations laid to drive the business forward with a clear focus on sales distribution to secondary providers. Get that right and the problem won’t be sales it’ll be infrastructure to meet the demand. It’s positive so you will not be sunk, this will tick up and up.
Repetitive waffle, short on detail. I’m still deep underwater here so am looking to average down, but I’m waiting for hard financial information before buying more. And I’ll probably kick myself over the next couple of weeks…..
Getting the share price up for a fund raise!
When considering market cap….and where the co is positioned, the SP is absolutely below realism. I just re/read the RNS…as I said earlier, the update was very clear.
The direction is positive. This week will be a good week - my prior posts was merely to say that the board wanted to assure shareholders that they were delivering on their strategy. Please research and make your own decisions….. this is my take on where the company is at.
That’s a very fair reason…dilution kills SP value so strategically a so uh no decision from the board’s perspective. That said, it could have been beneficial but that’s for someone with a crystal ball. Tomorrow I see this go higher not on sentiment, but remember, the foundations are solid and the reason for todays update was to steady the ship and give shareholders and potential investors a clear message….
I agree…the news was well overdue and clearly they have to state facts and not be misleading (market manipulation). Strategy delivery was mentioned and this is just the start of good things and profitability…it will reap rewards for shareholders imho…it will.
They mentioned that one of the reasons for not going through with the Materia deal was not to add more dilution. It's important for them to show that the company is progressing in order to drive the price northwards and as the GP service deal was part dependant on share options then any bit of progress is welcome.
The very fact they didn’t mention fund raising suggests that all is in order I would conclude…..
A comment on the financials would have been helpful/reassuring, even if it were on the basis that the company continues to perform within/ahead of guidance. But, we are where we are.
This is excellent and provides the platform for increased sales distribution and profit. They have invested heavily in the architecture and distribution platform and now it’s about reaching the secondary buyers network which will be only profitable so we should see this company move forward significantly in 2023. A very cheap SP imho…so….
GP Service is gaining more traction due to the situation with people unable to get an appointment and also a good platform to introduce their products. CE approval is still in process even though I thought we would have been nearer to an outcome. More new products on the horizon so considering the current climate for cannabis companies they are still well positioned to capitalise on their goals.
I'm happy with this RNS.
I was becoming disillusioned with this share ( I bought in at the start; D'oh) so I've done a lot of averaging down and I'm in a bit more than what I intended to be.
But happy to sit and watch for another 12mnths based on this
Re: small trades
There are platforms which allow commission free trades, minimum trade £2, so no surprise to see these on penny stock like KNB. Will be interested to hear others views on today's RNS....
I must say I thought this would drift lower…also the small trades seem odd as commission costs would distort value alone. I wish there would be some positive company communication!
At the moment it looks like a repeat is on the cards or maybe the Love Hemp situation has spooked a few. Hopefully time and patience will pay off in the med/long term .Bring on some good news :-)
Good read. Hopefully a positive market announcement will be forthcoming…..?